产品分类
联系我们
电话: 0519-85788828
传真: 0519-89960117
手机: 13775037613
E-mail: sales@chemrenpharm.com
地址: 江苏省常州市新北区百丈工业园
QQ:
2500035664
产品详细: |
Description of:Linsitinib(OSI906)
Linsitinib(OSI906) is a potential first-in-class selective small molecule, dual kinase inhibitor of both insulin-like growth factor-1 receptor (IGF-1R) and insulin receptor (IR). OSI-906 is currently in a Phase III clinical trial in adrenocortical carcinoma (ACC) and in a Phase I/II clinical trial in ovarian cancer. Theoretical analysis:Linsitinib(OSI906) M.Wt:421.49 Formula: C26H23N5O Solubility: Unknown Purity: >98% Storage: at -20℃ 2 years CAS No: 867160-71-2 Availability and price:Linsitinib(OSI906) Pakage:25mg/50mg/100mg/250mg/500mg/1g/5g Stock : in stock We offer significant discount for larger quantity order. For quotation, question, and order, please send email to : sales@chemrenpharm.com Quality control data: Quality Control by H-NMR,C-NMR,LC-MS,HPLC. Product will be shipped with supporting analytical data. Fast delivery about 4-5 working days |
相关产品 : |
|
|
|
|
||||||||
|
|